1. Others Metabolic Enzyme/Protease Immunology/Inflammation NF-κB Apoptosis
  2. Drug Intermediate Reactive Oxygen Species (ROS) Apoptosis Keap1-Nrf2 Heme Oxygenase (HO) Bcl-2 Family Caspase
  3. D-Leucine amide-CDDO-Me-HMP

D-Leucine amide-CDDO-Me-HMP 是一种由 CDDO-Me (HY-13324) 和ligustrazine (HY-N0264) 组成的前药。D-Leucine amide-CDDO-Me-HMP 可保护 CCl4 诱导的肝损伤。D-Leucine amide-CDDO-Me-HMP 能够抑制活性氧 (ROS) 的产生,减轻线粒体损伤并抑制细胞凋亡 (apoptosis)。D-Leucine amide-CDDO-Me-HMP 可用于肝脏损伤研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

D-Leucine amide-CDDO-Me-HMP

D-Leucine amide-CDDO-Me-HMP Chemical Structure

CAS No. : 2749600-16-4

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

D-Leucine amide-CDDO-Me-HMP is a prodrug composed of CDDO-Me (HY-13324) and ligustrazine (HY-N0264). D-Leucine amide-CDDO-Me-HMP can protect against CCl4-induced liver injury. D-Leucine amide-CDDO-Me-HMP can inhibit ROS production, alleviates mitochondrial damage and inhibits cell apoptosis. D-Leucine amide-CDDO-Me-HMP can be used for the research of liver injury[1].

体外研究
(In Vitro)

D-Leucine amide-CDDO-Me-HMP (CHL) (0.05-0.10 μM, 24 h) 在 CCl4 诱导的 LO2 和 RAW264.7 肝损伤细胞模型中显著提高细胞活力[1]
D-Leucine amide-CDDO-Me-HMP (0.05-0.10 μM, 24 h) 在 CCl4 诱导的 LO2 和 RAW264.7 肝损伤细胞模型中降低 ROS 水平,减轻线粒体损伤并抑制细胞凋亡[1]
D-Leucine amide-CDDO-Me-HMP (0.05-0.10 μM, 24 h) 在 CCl4 诱导的 LO2 细胞中显著上调 Nrf2 和 HO-1 蛋白的表达[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: CCl4 induced LO2 and RAW264.7 liver injury cells
Concentration: 0.05 and 0.10 μM
Incubation Time: 24 h
Result: Showed cell viability of 98.4% in LO2 cells and 92.6% in RAW264.7 cells.

Immunofluorescence[1]

Cell Line: CCl4 induced LO2 and RAW264.7 liver injury cells
Concentration: 0.05 and 0.10 μM
Incubation Time: 24 h
Result: Reduced the fluorescence intensity of DCF.
Reduced the fluorescence intensity of J-monomer and Increased the fluorescence intensity of J-aggregate.
体内研究
(In Vivo)

D-Leucine amide-CDDO-Me-HMP (CHL) (15-30 mg/kg,腹腔注射,在 CCl4 诱导肝损伤后给药) 可改善 CCl4 诱导的 C57BL/6 小鼠肝损伤模型的肝组织形态和病理损伤[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (8 weeks of age, 18–20 g, CCl4-induced liver injury)[1]
Dosage: 15 mg/kg, 30 mg/kg
Administration: Intraperitoneally injection
Result: Reduced serum levels of ALT and AST.
Alleviated steatosis and inflammatory infiltration.
Upregulated the expression of HO-1 (4.2-fold) and NQO1 (5.5-fold) in liver tissue.
Downregulated the expression of p-p65 (5-fold) and pro-apoptotic protein BAX.
Upregulated the expression of anti-apoptotic protein Bcl-2, and inhibited excessive activation of Caspase-3.
分子量

876.18

Formula

C53H73N5O6

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
D-Leucine amide-CDDO-Me-HMP
目录号:
HY-179613
需求量: